Keywords
Allergen
House dust mites
Ascaris lumbricoides
T epitope
Multi-epitopes
Funding data
-
Ministerio de Ciencia, Tecnología e Innovación
Grant numbers No121577758375
Abstract
Background:
Helminth infections for Ascaris lumbricoides and exposure to mite allergens stimulate a Th2 immune response present in allergic diseases. Helminth proteins are well known can modulate the host immune response and lessen the inflammation response. We evaluate the Ig E reactivity to a molecule constructed from A. lumbricoides T epitopes (MP1) in sera from patients suffering from T1D, LN, and JIA
Methods:
We designed and expressed a synthetic multi-epítope protein named MP1 from A. lumbricoides and house dust mites allergens. By indirect ELISA, we evaluated IgE-reactivity to MP1 and to the whole-body extract of Ascaris lumbricoidesin 45 sera from Colombian Caribbean patients with lupus nephritis (LN; n=25), type 1 diabetes (T1D; n=10) and Juvenil idiopathic arthritis (JIA; n=10). Individuals with poly autoimmunity were excluded. All patients were referred to the study by their specialist doctor.
Results:
IgE to whole-body extract of A. lumbricoides showed the following median concentrations: 484.2 ng/ml (IQR: 203.4) in JIA patients, 325.6 ng/ml (IQR: 179.3) in individuals with LN, and 424.7 ng/ml (IQR: 80.1) in T1D group. On the other hand, IgE-reactivity to MP1 was 126.4 ng/ml (IQR: 90.9) in JIA patients, 130.7 ng/ml (IQR: 94.8) in an individual with LN, and 148.8 ng/ml (IQR: 102.1) in T1D group. Although no statistical differences were observed between patient groups, the IgE to MP1 in all patients (n: 45) (IgE median: 134.2 ng/ml; IQR: 100) were significantly less compared to Ascaris extract (IgE median: 380.7 ng/ml; IQR: 175.8); (W:0.732; p-value: 1.034x10-7).
Conclusions:
These preliminary results suggest that MP1 showed antigenic properties with low IgE-reactivity compared to Ascaris lumbricoides extract in individuals with autoimmune diseases. Further studies are needed to understand better the immune response induced by this molecule.
References
Negahdaripour, M., Golkar, N., Hajighahramani, N., Kianpour, S., Nezafat, N., & Ghasemi, Y. (2017). Harnessing self-assembled peptide nanoparticles in epitope vaccine design. Biotechnology advances, 35(5), 575–596. https://doi.org/10.1016/j.biotechadv.2017.05.002
Negahdaripour, M., Nezafat, N., Eslami, M., Ghoshoon, M. B., Shoolian, E., Najafipour, S., Morowvat, M. H., Dehshahri, A., Erfani, N., & Ghasemi, Y. (2018). Structural vaccinology considerations for in silico designing of a multi-epitope vaccine. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 58, 96–109. https://doi.org/10.1016/j.meegid.2017.12.008
Rapin, N., Lund, O., Bernaschi, M., & Castiglione, F. (2010). Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PloS one, 5(4), e9862. https://doi.org/10.1371/journal.pone.0009862
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2024 Revista Alergia México